Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adrenergic blocking agents and the kidney.

J H Bauer

    Journal of Clinical Hypertension
    |September 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Different adrenergic antagonist classes impact kidney function differently. Peripheral adrenergic-neuronal blocking agents significantly reduce renal blood flow and glomerular filtration rate, causing fluid retention.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Chemiluminescent Probes for Imaging H<sub>2</sub>S in Living Animals.

    Chemical science·2015
    Same author

    THE TETANUS BACILLUS AS AN INTESTINAL SAPROPHYTE IN MAN.

    The Journal of experimental medicine·2009
    Same author

    STUDIES ON THE RELATION OF TETANUS BACILLI IN THE DIGESTIVE TRACT TO TETANUS ANTITOXIN IN THE BLOOD.

    The Journal of experimental medicine·2009
    Same author

    THE IMMUNITY PRODUCED BY THE GROWTH OF TETANUS BACILLI IN THE DIGESTIVE TRACT.

    The Journal of experimental medicine·2009
    Same author

    THE INCUBATION PERIOD OF YELLOW FEVER IN THE MOSQUITO.

    The Journal of experimental medicine·2009
    Same author

    ULTRAFILTRATION OF THE VIRUS OF POLIOMYELITIS.

    The Journal of experimental medicine·2009
    Same journal

    Low mortality from ischemic heart disease among urban blacks in South Africa.

    Journal of clinical hypertension·1987
    Same journal

    Hypertension: questions of prevalence, diagnosis, and management. Medical Technology and Practice Patterns Institute.

    Journal of clinical hypertension·1987
    Same journal

    Influence of perceived level of stress upon ambulatory blood pressure, heart rate, and respiratory frequency.

    Journal of clinical hypertension·1987
    Same journal

    Psychological aspects of catecholamine response patterns to pain and mental stress in essential hypertensive patients and controls.

    Journal of clinical hypertension·1987
    Same journal

    Anthropometric data, urinary sodium excretion, and isometric exercise in epidemiological study of arterial hypertension.

    Journal of clinical hypertension·1987
    Same journal

    Ten-year follow-up study of children with primary hypertension from Sofia, Bulgaria.

    Journal of clinical hypertension·1987
    See all related articles

    Area of Science:

    • Pharmacology
    • Nephrology
    • Cardiovascular Medicine

    Background:

    • Adrenergic antagonists are widely used to manage hypertension and other cardiovascular conditions.
    • Understanding their renal effects is crucial for patient management and risk assessment.
    • Previous reviews have not comprehensively analyzed the renal impact of various adrenergic antagonist subclasses.

    Purpose of the Study:

    • To review and synthesize the acute and chronic renal effects of major classes of adrenergic antagonists.
    • To compare the distinct impacts of beta-adrenergic antagonists, alpha 1-adrenergic antagonists, central alpha 2-adrenergic agonists, and adrenergic-neuronal blocking agents on renal function.

    Main Methods:

    • Literature review of studies examining the renal effects of specific adrenergic antagonist medications.

    Related Experiment Videos

  • Analysis of effects on glomerular filtration rate (GFR), effective renal plasma flow (ERPF/RBF), renal vascular resistance (RVR), and electrolyte/water balance.
  • Categorization of findings based on drug class: beta-blockers, alpha 1-blockers, central alpha 2-agonists, and adrenergic-neuronal blockers.

    • Main Results:

    • Beta-adrenergic antagonists generally show minimal impact on GFR, ERPF/RBF, and electrolyte excretion.
    • Alpha 1-adrenergic antagonists and central alpha 2-adrenergic agonists reduce RVR but have minimal effect on GFR and ERPF/RBF; alpha 1-blockers can cause sodium retention.
    • Peripheral adrenergic-neuronal blocking agents (guanadrel, guanethidine) decrease GFR and ERPF/RBF, reduce RVR, and lead to salt and water retention, increasing body fluid volume.

    Conclusions:

    • Adrenergic antagonist classes exhibit varied renal effects, with peripheral adrenergic-neuronal blocking agents posing the greatest risk for renal impairment and fluid overload.
    • Beta-adrenergic antagonists appear to be renally neutral in most clinical contexts.
    • Further research may be warranted to explore long-term renal consequences and optimal use in patients with pre-existing renal conditions.